This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT05493501
Brief Title: Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer

First Submitted : June 24, 2022
First Submitted that Met QC Criteria : August 5, 2022
First Posted : August 9, 2022

Last Update Submitted that Met QC Criteria : October 4, 2023
Last Update Posted : October 6, 2023